Bayesian Capital Management, LP Novo Nordisk A S Transaction History

Bayesian Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $318,641 - $382,783	3,630 New	3,630 $375,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $1.27 Million - $1.68 Million	12,400 Added 178.21%	19,358 $2.62 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $400,176 - $491,106	4,200 Added 152.28%	6,958 $693,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $57,607 - $67,969	558 Added 25.36%	2,758 $307,000
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $204,820 - $247,588	2,200 New	2,200 $244,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $328,580 - $401,233	-3,427 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $289,307 - $365,386	3,427 New	3,427 $329,000
Q4 2017 Feb 12, 2018	SELL	$47.53 - $53.73 $1.99 Million - $2.25 Million	-41,838 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $1.72 Million - $2.06 Million	41,838	41,838 $2.01 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.